Menopause and Cancers
- PMID: 26316246
- DOI: 10.1016/j.ecl.2015.05.012
Menopause and Cancers
Abstract
Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.
Keywords: Cancer; Cancer prevention; Cancer screening; Hormone replacement; Lifestyle modification; Menopause.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Hormone replacement therapy in gynecologic cancer survivors: why not?Gynecol Oncol. 2011 Aug;122(2):447-54. doi: 10.1016/j.ygyno.2011.03.012. Epub 2011 Apr 6. Gynecol Oncol. 2011. PMID: 21474167 Review.
-
Management of menopausal symptoms in women with gynecologic cancers.Gynecol Oncol. 2017 Aug;146(2):427-435. doi: 10.1016/j.ygyno.2017.06.013. Epub 2017 Jun 16. Gynecol Oncol. 2017. PMID: 28625396 Review.
-
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.Climacteric. 2001 Sep;4(3):181-93. Climacteric. 2001. PMID: 11588941 Review.
-
Hormone replacement therapy and cancer.Gynecol Endocrinol. 2001 Dec;15(6):453-65. Gynecol Endocrinol. 2001. PMID: 11826770 Review.
-
Hormone replacement therapy and women with premature menopause--a cancer survivorship issue.Eur J Cancer. 2011 Jul;47(11):1623-32. doi: 10.1016/j.ejca.2011.04.007. Epub 2011 May 9. Eur J Cancer. 2011. PMID: 21561765
Cited by
-
Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives.Int J Womens Health. 2023 Jan 25;15:103-109. doi: 10.2147/IJWH.S334719. eCollection 2023. Int J Womens Health. 2023. PMID: 36721498 Free PMC article. Review.
-
Sex bias in tumor immunity: insights from immune cells.Theranostics. 2025 Mar 31;15(11):5045-5072. doi: 10.7150/thno.106465. eCollection 2025. Theranostics. 2025. PMID: 40303343 Free PMC article. Review.
-
Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.Ann Transl Med. 2021 Feb;9(3):239. doi: 10.21037/atm-20-2003. Ann Transl Med. 2021. PMID: 33708866 Free PMC article.
-
Age at menopause is inversely related to the prevalence of common gynecologic cancers: a study based on NHANES.Front Endocrinol (Lausanne). 2023 Nov 16;14:1218045. doi: 10.3389/fendo.2023.1218045. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38034008 Free PMC article.
-
Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.PLoS One. 2024 Feb 26;19(2):e0299114. doi: 10.1371/journal.pone.0299114. eCollection 2024. PLoS One. 2024. PMID: 38408048 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
